(Q38491222)

English

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

scientific article published on October 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

anti-retroviral agent

0 references

author name string

CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe) Collaboration

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

224-231

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Clinical course of primary HIV infection: consequences for subsequent course of infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

The early introduction of HIV infection among Norwegians at highest risk

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Flexible regression models with cubic splines

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2000.00033.X

21 January 2018

Identifiers

10.1046/J.1468-1293.2000.00033.X

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38491222&oldid=1508596073"